GPC3 and hepatocellular carcinoma: The effect of isoform-specific HIFα ASO treatment on HCC tumorigenesis was further investigated via assessment of hepatic mRNA expression of the HCC tumor markers α-fetoprotein (AFP) and glypican-3 (GPC3).